4D Molecular Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 11/14/2024 | 7.38 M | $79.81 M | 88.22% | 13.29% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 5.10 M | $55.11 M | 0.00% | 9.18% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.87 M | $52.63 M | 100.00% | 8.76% |
| VR ADVISER, LLC | 11/14/2024 | 4.40 M | $47.56 M | 0.00% | 7.92% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 4.10 M | $44.28 M | 0.86% | 7.37% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 3.59 M | $38.82 M | -13.14% | 6.46% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 3.14 M | $33.92 M | -1.87% | 5.65% |
| VANGUARD GROUP INC | 11/13/2024 | 2.77 M | $29.92 M | 9.47% | 4.98% |
| STATE STREET CORP | 11/14/2024 | 2.12 M | $22.88 M | 1.79% | 3.81% |
| MORGAN STANLEY | 11/14/2024 | 1.70 M | $18.40 M | 16.58% | 3.06% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 1.54 M | $16.68 M | 238.27% | 2.78% |
| NOVO HOLDINGS A/S | 10/24/2024 | 1.50 M | $16.22 M | 7.14% | 2.70% |
| REDMILE GROUP, LLC | 11/14/2024 | 1.26 M | $13.64 M | 17.57% | 2.27% |
| BRAIDWELL LP | 11/14/2024 | 1.23 M | $13.25 M | 231.69% | 2.21% |
| CASDIN CAPITAL, LLC | 11/14/2024 | 1.15 M | $12.43 M | 43.75% | 2.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.04 M | $11.21 M | -2.29% | 1.87% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 838,492 | $9.06 M | -51.94% | 1.51% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2024 | 803,490 | $8.69 M | -5.49% | 1.45% |
| EAGLE HEALTH INVESTMENTS LP | 11/12/2024 | 462,911 | $5.00 M | 0.00% | 0.83% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 11/13/2024 | 459,000 | $4.96 M | -34.99% | 0.83% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 422,856 | $4.57 M | -52.01% | 0.76% |
| DECHENG CAPITAL LLC | 11/15/2024 | 397,835 | $4.30 M | 14.37% | 0.72% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 351,653 | $3.80 M | 98.94% | 0.63% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 338,317 | $3.66 M | 0.13% | 0.61% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 336,000 | $3.63 M | 100.00% | 0.60% |
| JPMORGAN CHASE & CO | 11/08/2024 | 315,983 | $3.42 M | -8.62% | 0.57% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 290,031 | $3.14 M | -19.81% | 0.52% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 256,995 | $2.78 M | 12.92% | 0.46% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 208,815 | $2.26 M | -60.80% | 0.38% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 166,190 | $1.80 M | -7.39% | 0.30% |
| MARSHALL WACE, LLP | 11/14/2024 | 165,193 | $1.79 M | -11.12% | 0.30% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 161,296 | $1.74 M | 86.56% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 146,405 | $1.58 M | -13.58% | 0.26% |
| PERIGON WEALTH MANAGEMENT, LLC | 10/16/2024 | 146,170 | $1.58 M | 0.00% | 0.26% |
| JANE STREET GROUP, LLC | 11/15/2024 | 145,512 | $1.57 M | 8.98% | 0.26% |
| CITADEL ADVISORS LLC | 11/14/2024 | 127,648 | $1.38 M | 74.39% | 0.23% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 123,468 | $1.33 M | 0.00% | 0.22% |
| BARCLAYS PLC | 11/19/2024 | 114,848 | $1.24 M | 141.04% | 0.21% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 105,972 | $1.15 M | 285.03% | 0.19% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 100,973 | $1.09 M | -71.55% | 0.18% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 11/08/2024 | 100,863 | $1.09 M | 175.79% | 0.18% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 98,800 | $1.07 M | 98.79% | 0.18% |
| PRIVIUM FUND MANAGEMENT B.V. | 11/01/2024 | 98,500 | $1.06 M | 146.25% | 0.18% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 90,348 | $976,662 | -5.46% | 0.16% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 84,322 | $911,521 | 100.00% | 0.15% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 83,226 | $899,673 | 145.91% | 0.15% |
| UBS GROUP AG | 11/14/2024 | 80,289 | $867,925 | 19.58% | 0.14% |
| TWINBEECH CAPITAL LP | 11/14/2024 | 76,310 | $824,911 | 30.18% | 0.14% |
| JUMP FINANCIAL, LLC | 11/14/2024 | 75,493 | $816,079 | 157.09% | 0.14% |
| ALGERT GLOBAL LLC | 11/12/2024 | 73,436 | $794,000 | 342.71% | 0.13% |
4D Molecular Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 163 institutional investors and hedge funds held shares of 4D Molecular Therapeutics, Inc.. The most heavily invested institutionals were:
BVF INC/IL: 7.38 M
RA CAPITAL MANAGEMENT, L.P.: 5.1 M
BlackRock Funding, Inc. /DE: 4.87 M
VR Adviser, LLC: 4.4 M
Deep Track Capital, LP: 4.1 M
GOLDMAN SACHS GROUP INC: 3.59 M
103.86% of 4D Molecular Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 61.27 M shares in the last 24 months. This purchase volume represents approximately $355.98 M in transactions.